# Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

> **NCT01666041** · PHASE4 · COMPLETED · sponsor: **Gachon University Gil Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** placebo
- **DRUG:** fenofibrate/omega
- **DRUG:** fenofibrate

## Key facts

- **NCT ID:** NCT01666041
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666041, "Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01666041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*